Connect your AI

Neuronetics STIM Clinical Services — Research And Development Expense

Other segment segments

Medical Device

$1.31M-16.6%

Similar metrics at other companies

RNTXClinical Operation Activities — Research And Development Expense

$1.96M+191%

FLGTLaboratory Services — Research And Development Expense

$6.46M+31.0%

MPLTClinical Trial — Research And Development Expense

$24.82M+1,180%

GERNResearch and clinical expenses — R&D

$13M-5.1%

INVAExternal Services — Research And Development Expense

$2.61M-14.6%

CAMPR&D — Clinical and preclinical expenses

$4.63M+3.4%

Other financials

Income statement

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

Market cap$90.46M-59.6%

Enterprise value$162.64M-44.6%

P/S0.6×-1.4×

Profitability

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's clinical services — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Neuronetics's clinical services — research and development expense?: Neuronetics (STIM) reported clinical services — research and development expense of $60K in Q1 2026.
How has Neuronetics's clinical services — research and development expense changed year-over-year?: Neuronetics's clinical services — research and development expense increased by 17.6% year-over-year, from $51K to $60K.
What does clinical services — research and development expense mean?: This metric tracks the costs dedicated to research and development activities specifically focused on enhancing or expanding the clinical services offerings. It indicates the company's commitment to innovation and long-term improvement of its medical service capabilities.